AG73-modified Bubble liposomes for targeted ultrasound imaging of tumor neovasculature

Biomaterials

Volumn 34, Issue 2, 2013, Pages 501-507

  Negishi, Yoichi ^a   Hamano, Nobuhito ^a   Tsunoda, Yuka ^a   Oda, Yusuke ^b   Choijamts, Batsuren ^c   Endo Takahashi, Yoko ^a   Omata, Daiki ^b   Suzuki, Ryo ^b   Maruyama, Kazuo ^b   Nomizu, Motoyoshi ^a   Emoto, Makoto ^c   Aramaki, Yukihiko ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

^c INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Contrast agent; Microbubble; Tumor targeting peptide; Ultrasound imaging

Indexed keywords

BUBBLE LIPOSOMES; CONTRAST AGENT; CONTRAST IMAGING; GENE DELIVERY; IN-VITRO; LAMININ; MICRO-BUBBLE; NEOVASCULATURE; SYNDECAN-2; TUMOR TARGETING; ULTRASOUND CONTRAST AGENT; ULTRASOUND IMAGING;

AMINO ACIDS; BLOOD VESSELS; DIAGNOSIS; FLOW CYTOMETRY; GENE TRANSFER; IMAGING TECHNIQUES; LIPOSOMES; MOLECULAR IMAGING; PEPTIDES; TUMORS;

ULTRASONIC IMAGING;

AG73 MODIFIED BUBBLE LIPOSOME PEPTIDE; CONTRAST MEDIUM; PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CELL MEMBRANE PERMEABILITY; CIRCULATION; CLINICAL PRACTICE; CONTROLLED STUDY; ECHOGRAPHY; FLOW CYTOMETRY; FLOW RATE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SHEAR STRESS; TUMOR VASCULARIZATION;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CONTRAST MEDIA; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LAMININ; LIPOSOMES; MALE; MICE; MICE, INBRED BALB C; MICROBUBBLES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OLIGOPEPTIDES; SYNDECAN-2;

MUS;

EID: 84868194903     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.09.056     Document Type: Article

References (41)

1. Willmann J.,K., van Bruggen N., Dinkelborg L.,M., Gambhir S.,S. Molecular imaging in drug development. Nat Rev Drug Discov 2008, 7:591-607.
2. Lindner J.,R. Microbubbles in medical imaging: current applications and future directions. Nat Rev Drug Discov 2004, 3:527-533.
3. Wilson S.,R., Burns P.,N. Microbubble-enhanced US in body imaging: what role?. Radiology 2010, 257(1):24-39.
4. Deshpande N., Needles A., Willmann J.,K. Molecular ultrasound imaging: current status and future directions. Clin Radiol 2010, 65(7):567-581.
5. Danila M., Popescu A., Sirli R., Sporea I., Martie A., Sendroiu M. Contrast enhanced ultrasound (CEUS) in the evaluation of liver metastases. Med Ultrason 2010, 12(3):233-237.
6. Kiessling F., Huppert J., Palmowski M. Functional and molecular ultrasound imaging: concepts and contrast agents. Curr Med Chem 2009, 16:627-642.
7. Klibanov A.,L. Ligand-carrying gas-filled microbubbles: ultrasound contrast agents for targeted molecular imaging. Bioconjug Chem 2005, 16:9-17.
8. Dayton P.,A., Rychak J.,J. Molecular ultrasound imaging using microbubble contrast agents. Front Biosci 2007, 12:5124-5142.
9. Ferrara K.,W., Borden M.,A., Zhang H. Lipid-shelled vehicles: engineering for ultrasound molecular imaging and drug delivery. Acc Chem Res 2009, 42(7):881-892.
10. Allen T.,M., Hansen C., Martin F., Redemann C., Yau-Young A. Liposomes containing synthetic lipid derivatives of poly(ethyleneglycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1991, 1066:29-36.
11. Blume G., Cevc G. Liposomes for the sustained drug release in vivo. Biochim Biophys Acta 1990, 1029:91-97.
12. Harata M., Soda Y., Tani K., Ooi J., Takizawa T., Chen M., et al. CD19-targeting liposomes containing imatinib efficiently kill Philadelphia chromosome-positive acute lymphoblastic leukemia cells. Blood 2004, 104:1442-1449.
13. Maruyama K., Yuda T., Okamoto A., Kojima S., Suginaka A., Iwatsuru M. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochim Biophys Acta 1992, 1128:44-49.
14. Maruyama K., Ishida O., Kasaoka S., Takizawa T., Utoguchi N., Shinohara A., et al. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT). J Control Release 2004, 98:195-207.
15. Suzuki R., Takizawa T., Negishi Y., Hagisawa K., Tanaka K., Sawamura K., et al. Gene delivery by combination of novel liposomal bubbles with perfluoropropane and ultrasound. J Control Release 2007, 117:130-136.
16. Suzuki R., Takizawa T., Negishi Y., Utoguchi N., Maruyama K. Effective gene delivery with novel liposomal bubbles and ultrasonic destruction technology. Int J Pharm 2008, 354:49-55.
17. Suzuki R., Takizawa T., Negishi Y., Utoguchi N., Sawamura K., Tanaka K., et al. Tumor specific ultrasound enhanced gene transfer in vivo with novel liposomal bubbles. J Control Release 2008, 125:137-144.
18. Negishi Y., Matsuo K., Endo-Takahashi Y., Suzuki K., Matsuki Y., Takagi N., et al. Delivery of an angiogenic gene into ischemic muscle by novel bubble liposomes followed by ultrasound exposure. Pharm Res 2011, 28:712-719.
19. Negishi Y., Tsunoda Y., Endo-Takahashi Y., Oda Y., Suzuki R., Maruyama K., et al. Local gene delivery system by bubble liposomes and ultrasound exposure into joint synovium. J Drug Deliv 2011, 2011. 203986.
20. Endo-Takahashi Y., Negishi Y., Kato Y., Suzuki R., Maruyama K., Aramaki Y. Efficient siRNA delivery using novel siRNA-loaded bubble liposomes and ultrasound. Int J Pharm 2012, 422(1-2):504-509.
21. Negishi Y., Endo-Takahashi Y., Matsuki Y., Kato Y., Takagi N., Suzuki R., et al. Systemic delivery systems of angiogenic gene by novel bubble liposomes containing cationic lipid and ultrasound exposure. Mol Pharm 2012, 9(6):1834-1840.
22. Kerbel R., Folkman J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2002, 2:727-739.
23. Cross M.,J., Claesson-Welsh L. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 2001, 22:201-207.
24. Carey D.,J. Syndecans: multifunctional cell-surface co-receptors. Biochem J 1997, 327:1-16.
25. Hoffman M.,P., Nomizu M., Roque E., Lee S., Jung D.W., Yamada Y., et al. Laminin-1 and laminin-2 G-domain synthetic peptides bind syndecan-1 and are involved in acinar formation of a human submandibular gland cell line. J Biol Chem 1998, 273:28633-28641.
26. Suzuki N., Ichikawa N., Kasai S., Yamada M., Nishi N., Morioka H., et al. Syndecan binding sites in the laminin alpha1chain G domain. Biochemistry 2003, 42:12625-12633.
27. Couchman J.,R. Syndecans: proteoglycan regulators of cell-surface microdomains?. Nat Rev Mol Cell Biol 2003, 4:926-937.
28. Fears C.,Y., Gladson C.,L., Woods A. Syndecan-2 is expressed in the microvasculature of gliomas and regulates angiogenic processes in microvascular endothelial cells. J Biol Chem 2006, 281:14533-14536.
29. Halden Y., Rek A., Atzenhofer W., Szilak L., Wabnig A., Kungl A.,J. Interleukin-8 binds to syndecan-2 on human endothelial cells. Biochem J 2004, 377(Pt 2):533-538.
30. Mertens G., Cassiman J.J., Van den Berghe H., Vermylen J., David G. Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. Core protein characterization and antithrombin III binding properties. J Biol Chem 1992, 267:20435-20443.
31. Negishi Y., Omata D., Iijima H., Takabayashi Y., Suzuki K., Endo Y., et al. Enhanced laminin-derived peptide AG73-mediated liposomal gene transfer by bubble liposomes and ultrasound. Mol Pharm 2010, 7(1):217-226.
32. Negishi Y., Hamano N., Omata D., Fujisawa A., Manandhar M., Nomizu M., et al. Effect of doxorubicin-encapsulating AG73 peptide-modified liposomes on tumor selectively and cytotoxicity. Results Pharm Sci 2011, 1:68-75.
33. Hwang T., Han H.D., Song C.K., Seong H., Kim J.H., Chen X., et al. Anticancer drug-phospholipid conjugate for enhancement of intracellular drug delivery. Macromol Symp 2007, 249-250:109-115.
34. Mannell H., Pircher J., Räthel T., Schilberg K., Zimmermann K., Pfeifer A., et al. Targeted endothelial gene delivery by ultrasonic destruction of magnetic microbubbles carrying lentiviral vectors. Pharm Res 2012, 5:1282-1294.
35. Weller G.,E., Wong M.,K., Modzelewski R.,A., Lu E., Klibanov A.,L., Wagner W.,R., et al. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res 15 Jan 2005, 65(2):533-539.
36. Willmann J.,K., Paulmurugan R., Chen K., Gheysens O., Rodriguez-Porcel M., Lutz A.,M., et al. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology 2008, 246(2):508-518.
37. Franke R.,P., Gräfe M., Schnittler H., Seiffge D., Mittermayer C., Drenckhahn D. Induction of human vascular endothelial stress fibres by fluid shear stress. Nature 1984, 307(5952):648-649.
38. Giavazzi R., Foppolo M., Dossi R., Remuzzi A. Rolling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions. J Clin Invest 1993, 92(6):3038-3044.
39. Yamawaki H., Lehoux S., Berk B.,C. Chronic physiological shear stress inhibits tumor necrosis factor-induced proinflammatory responses in rabbit aorta perfused ex vivo. Circulation 2003, 108(13):1619-1625.
40. Pysz M.,A., Foygel K., Rosenberg J., Gambhir S.,S., Schneider M., Willmann J.,K. Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). Radiology 2010, 256(2):519-527.
41. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000, 65:271-284.